First-Line Vasoactive Agents for Pediatric Shock After Fluid Resuscitation
Either epinephrine or norepinephrine should be initiated as the first-line vasoactive agent in pediatric shock after adequate fluid resuscitation (40-60 mL/kg), with both agents preferred over dopamine.
Recommended Approach
Initial Vasoactive Selection
The 2020 Surviving Sepsis Campaign guidelines explicitly recommend against using dopamine as first-line therapy, suggesting epinephrine over dopamine (weak recommendation) and norepinephrine over dopamine (weak recommendation) 1. However, the guidelines notably could not recommend a specific first-line agent between epinephrine and norepinephrine, acknowledging both as acceptable choices 1.
Practical starting approach:
- Start epinephrine OR norepinephrine at 0.05-0.1 µg/kg/min after 40-60 mL/kg fluid resuscitation if abnormal perfusion persists 1
- Both can be administered peripherally or via intraosseous access if central access is not immediately available 1, 2
- Dopamine may be substituted only if epinephrine or norepinephrine is not readily available 1
Evidence Supporting This Recommendation
Recent meta-analysis data (2024) shows norepinephrine was associated with the lowest mortality rate (7%) among single vasoactive agents, compared to epinephrine (17%) and dopamine (11%) 3. When directly comparing dopamine versus epinephrine, dopamine showed a trend toward higher mortality (PR 1.38) and significantly higher need for mechanical ventilation (PR 1.12) 3.
A 2025 feasibility trial comparing epinephrine versus norepinephrine found faster shock resolution with norepinephrine (median 14 hours vs 31 hours) and fewer adverse events requiring stopping criteria (1/15 vs 7/16) 4, though this was a small single-center study.
Hemodynamic Phenotype Considerations
While the guidelines suggest not using bedside clinical signs in isolation to categorize shock as "warm" or "cold" 1, a pragmatic approach based on clinical presentation can guide initial selection:
For vasoplegic/warm shock (wide pulse pressure, low diastolic BP, bounding pulses):
- Norepinephrine is preferred due to its potent alpha-adrenergic effects to restore vascular tone 5
For cold shock (prolonged capillary refill, weak pulses, narrow pulse pressure):
- Epinephrine may be preferred for combined inotropic and vasopressor effects 5, 6
- Alternatively, dopamine or dobutamine can be considered 6
Route of Administration
Critical point: Central venous access is not a prerequisite for initiating vasoactive therapy 1, 2. Both epinephrine and norepinephrine can be safely administered via:
- Peripheral IV (using dilute preparations)
- Intraosseous access
- Central venous catheter when available
This represents a significant shift toward early initiation rather than delaying for central access 2.
Escalation Strategy
If shock persists despite first-line therapy:
- Optimize the initial agent by titrating dose upward
- Add vasopressin as adjunctive therapy when high-dose catecholamines are required (no specific threshold defined; use clinical judgment) 1
- Consider inodilators (milrinone, dobutamine) if cardiac dysfunction is present, though guidelines could not make a firm recommendation 1
- Stress-dose corticosteroids in selected refractory cases 6
Monitoring Targets
Use advanced hemodynamic variables when available (cardiac output, systemic vascular resistance, ScvO2) in addition to clinical assessment 1. Monitor serial lactate trends to guide resuscitation adequacy 1. Target the lowest acceptable MAP (5th percentile for age may be sufficient if end-organ perfusion is adequate) 5.
Common Pitfalls
- Delaying vasoactive initiation while pursuing central access—start peripherally if needed
- Using dopamine as first-line—it is associated with worse outcomes compared to epinephrine or norepinephrine 3
- Excessive fluid administration—only 33-50% of septic patients respond to fluid boluses; consider early low-dose norepinephrine (0.05-0.1 µg/kg/min) with restricted fluids 5
- Relying solely on clinical signs to phenotype shock—use available hemodynamic monitoring 1